A RETROSPECTIVE ANALYSIS OF TREATMENT OUTCOME IN 106 CASES OF LOCALIZED GASTRIC NON-HODGKIN LYMPHOMAS

被引：29

作者：

BRINCKER, H

DAMORE, F

机构：

[1] Department of Hematology, Odense University Hospital

来源：

LEUKEMIA & LYMPHOMA | 1995年 / 18卷 / 3-4期

关键词：

POPULATION-BASED; GASTRIC LYMPHOMA; PROGNOSTIC FACTORS; SURGERY; RADIOTHERAPY; COMPLICATIONS;

D O I：

10.3109/10428199509059619

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

197 cases of gastric lymphoma were reported to a population-based Danish registry of non-Hodgkin's lymphomas. 106 of these cases were localized, representing stages IE and II(1)E, and were analyzed retrospectively, using Cox regression analysis, 67 had surgical resection, 51 chemotherapy, and 55 radiotherapy, or combinations thereof. No type of treatment showed any superiority as regards survival (p = 0.13). Overall 5-year survival was 67%. The pretherapeutic presence of fever or S-LDH-elevation had a far more significant influence on survival than histology or any of the treatments or treatment combinations. Surgical resection was associated with a significantly higher risk of late complications than radiotherapy, suggesting that radiotherapy may be preferable to surgery as the primary treatment in localized gastric lymphoma. It could not be determined from the available data whether the addition of chemotherapy to the primary treatment provides any survival benefit.

引用

页码：281 / 288

页数：8

共 35 条

[1]

Haber D.A., Mayer R.J., Primary gastrointestinal lymphoma, Semin. Oncol., 15, pp. 154-169, (1988)

[2]

Varsos G., Yahalom J., Alternatives in the management of gastric lymphoma, Leuk. Lymphoma, 4, pp. 1-8, (1991)

[3]

Aviles A., Diaz-Maqueo J.C., de la Torre A., Rodriguez L., Guzman R., Talavera A., Garcia E.L., Is sugery necessary in the treatment of primary gastric non-Hodgkin lymphoma?, Leuk, Lymphoma, 5, pp. 365-369, (1991)

[4]

d'Amore F., Christensen B.E., Brincker H., Pedersen N.T., Thorling K., Hastrup J., Pedersen M., Jensen M.K., Johansen P., Andersen E., Bach B., Sorensen E., Clinicopathological features and prognostic factors in extranodal non-Hodgkin lymphomas, Eur. J. Cancer, 7, pp. 1201-1208, (1991)

[5]

d'Amore F., Brincker H., Christensen B.E., Thorling K., Pedersen M., Nielsen J.L., Sandberg E., Pedersen N.T., Sorensen E., Non-Hodgkin's lymphoma in the elderly: A study of 602 patients aged 70 or older from a Danish population-based registry, Ann. Oncol., 3, pp. 379-386, (1992)

[6]

Musshoff K., Klinische Stadieeinteilung der nicht-Hodgkin Lymphoma, Strahlentherapie., 153, pp. 218-221, (1977)

[7]

d'Amore F., Brincker H., Gronbak K., Thorling K., Pedersen M., Jensen M.K., Andersen E., Pedersen N.T., Mortensen L.S., Non-Hodgkin's lymphoma of the gastrointestinal tract. A population-based analysis of incidence, geographic distribution, clinico-pathologic presentation features and prognosis, J. Clin. Oncol., (1994)

[8]

Lennert K., Malignant lymphomas other than Hodgkin 's disease., (1978)

[9]

National Cancer Institute Sponsored Study of Classifications of non-Hodgkin's Lymphomas., Summary and description of a working formulation for clinical usage, Cancer, 49, pp. 2112-2135, (1982)

[10]

Tarone R.E., Ware J., On distribution-free tests for survival of survival distributions, Biometrika, 64, pp. 156-160, (1977)

← 1 2 3 4 →